Results 21 to 30 of about 1,227,969 (402)

Lychee seed polyphenol protects blood–retinal barrier by increasing tight joint proteins and inhibiting the activation of TLR4/MYD88/NF-κB-mediated NLRP3 inflammasome

open access: yesFood and Agricultural Immunology, 2021
Emerging evidence indicates that blood–retinal barrier (BRB) damage is the main cause of diabetic retinopathy (DR), and the downregulation of tight proteins (TJs) located between endothelial cells and the activation of NLRP3 inflammasome-mediated ...
Jing Wei   +8 more
doaj   +1 more source

Preclinical evaluation of a novel antibody–drug conjugate OBI-992 for Cancer therapy

open access: goldScientific Reports
Trophoblast cell surface antigen 2 (TROP2), a transmembrane glycoprotein highly expressed in a variety of epithelial cancers, has been considered as a primary therapeutic target for the development of antibody–drug conjugates (ADCs).
Ting-Yu Chang   +14 more
doaj   +2 more sources

Two preclinical tests to evaluate anticancer activity and to help validate drug candidates for clinical trials. [PDF]

open access: yes, 2015
Current approaches to assessing preclinical anticancer activity do not reliably predict drug efficacy in cancer patients. Most of the compounds that show remarkable anticancer effects in preclinical models actually fail when tested in clinical trials. We
López Lázaro, Miguel
core   +6 more sources

P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma

open access: yesHemaSphere, 2022
Mia Lohmann   +10 more
doaj   +2 more sources

Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study

open access: yesCancer Medicine, 2023
Background Anti‐angiogenic therapy with bevacizumab (BEV), an anti‐VEGF antibody, plays a critical role in the treatment of ovarian cancer. However, despite an encouraging initial response, most tumors become resistant to BEV over time, and a new ...
Tianyue Zhai   +6 more
doaj   +1 more source

In vitro effects of European and Latin-American medicinal plants in CYP3A4 gene expression, glutathione levels, and P-glycoprotein activity

open access: yesFrontiers in Pharmacology, 2022
Many medicinal plants species from European -such as Artemisia absinthium, Equisetum arvense, Lamium album, Malva sylvestris, Morus nigra, Passiflora incarnata, Frangula purshiana, and Salix alba- as well as Latin American traditions -such as Libidibia ...
Andre Luis Dias Araujo Mazzari   +13 more
doaj   +1 more source

A network pharmacology-based approach to explore the active ingredients and molecular mechanism of Lei-gong-gen formula granule on a spontaneously hypertensive rat model

open access: yesChinese Medicine, 2021
Background Lei-gong-gen formula granule (LFG) is a folk prescription derived from Zhuang nationality, the largest ethnic minority among 56 nationalities in China.
Qiaofeng Li   +12 more
doaj   +1 more source

Animal models of chemotherapy-induced cognitive decline in preclinical drug development

open access: yesPsychopharmacology, 2021
Chemotherapy-induced cognitive impairment (CICI), chemobrain, and chemofog are the common terms for mental dysfunction in a cancer patient/survivor under the influence of chemotherapeutics.
Jeena John   +4 more
semanticscholar   +1 more source

IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation

open access: yesBiomolecules & Biomedicine, 2022
Preclinical models of tumors have the potential to become valuable tools for commercial drug research and development, and 3D culture systems are gaining traction in this area, particularly in prostate cancer (PCa) research.
Yipeng Xu   +8 more
doaj   +1 more source

Drug-Eluting Stents in Preclinical Studies [PDF]

open access: yesCirculation: Cardiovascular Interventions, 2008
Coronary drug-eluting stents are commonplace in clinical practice with acceptable safety and efficacy. Preclinical evaluation of novel drug-eluting stent technologies has great importance for understanding safety and possibly efficacy of these technologies, and well-defined preclinical testing methods clearly benefit multiple communities within the ...
Keith A. Robinson   +11 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy